Multiple sclerosis (MS) is the most common neurological disorder among young adults. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
A precise description of the clinical subtypes of multiple sclerosis is necessary in order to better classify each patient’s disease and better tailor their immunomodulatory therapy according to its course.
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
